Biotech Values

[10nisman]

<<< What is the $2.7 billion figure? Perhaps U.S. and non-U.S., non-Europe revenue? If so, with two generics won't price and total revenue decline? >>>

$2.7 billion is the U.S. market for Lovenox... I assumed a 35% price decline for the lower end of the range. The point of my message was not to get into particular assumptions but to quickly show how MNTA's current share price already fully discounts TEVA obtaining approval.

10nis